<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Ups J Med Sci</journal-id><journal-id journal-id-type="publisher-id">UPS</journal-id><journal-title-group><journal-title>Upsala Journal of Medical Sciences</journal-title></journal-title-group><issn pub-type="ppub">0300-9734</issn><issn pub-type="epub">2000-1967</issn><publisher><publisher-name>Informa Healthcare</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">22335390</article-id><article-id pub-id-type="pmc">3282237</article-id><article-id pub-id-type="doi">10.3109/03009734.2011.629749</article-id><article-id pub-id-type="publisher-id">UPS_A_629749_O</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Articles</subject></subj-group></article-categories><title-group><article-title>Dexmedetomidine reduces the incidence of fentanyl-induced cough: A double-blind, randomized, and placebo-controlled study</article-title></title-group><contrib-group><contrib id="a1" contrib-type="author" corresp="no"><name><surname>He</surname><given-names>Liang</given-names></name><xref ref-type="aff" rid="AF0001"/></contrib><contrib id="a2" contrib-type="author" corresp="yes"><name><surname>Xu</surname><given-names>Jun-Mei</given-names></name><xref ref-type="aff" rid="AF0001"/></contrib><contrib id="a3" contrib-type="author" corresp="no"><name><surname>Dai</surname><given-names>Ru-Ping</given-names></name><xref ref-type="aff" rid="AF0001"/></contrib><aff id="AF0001"><institution>Department of Anesthesia</institution>, <addr-line>The Second Xiangya Hospital of Central South University, Changsha</addr-line>, <country>China</country></aff></contrib-group><author-notes><corresp id="c1">Correspondence: Jun-Mei Xu, MD PhD, <institution>Department of Anesthesia</institution>, <addr-line>The Second Xiangya Hospital of Central South University, Changsha, Hunan Province, 410011</addr-line>, <country>China</country>. <email xlink:href="doctorjmxu@163.com">doctorjmxu@163.com</email></corresp></author-notes><pub-date pub-type="ppub"><month>3</month><year>2012</year></pub-date><pub-date pub-type="epub"><day>15</day><month>2</month><year>2012</year></pub-date><volume>117</volume><issue>1</issue><fpage>18</fpage><lpage>21</lpage><history><date date-type="received"><day>13</day><month>7</month><year>2011</year></date><date date-type="accepted"><day>03</day><month>10</month><year>2011</year></date></history><permissions><copyright-statement>&#x000a9; Informa Healthcare</copyright-statement><copyright-year>2012</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.5/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the source is credited.</license-p></license></permissions><abstract><sec><title>Objectives.</title><p> The incidence of fentanyl-induced cough (FIC) during induction of general anesthesia varies around 40% and is undesirable. It increases intracranial, intraocular, and intra-abdominal pressures. This prospective, randomized, double-blind, placebo-controlled study evaluated the effect of dexmedetomidine (DEX) pretreatment on the incidence and severity of FIC.</p></sec><sec><title>Methods.</title><p> Altogether 300 patients undergoing elective surgical procedures were randomly allocated into three groups (I, II, III; <italic>n</italic> = 100) and administered intravenously, over 10 min, 10 mL isotonic saline, DEX 0.5 &#x003bc;g/kg in 10 mL isotonic saline, or DEX 1 &#x003bc;g/kg in 10 mL isotonic saline, respectively. All groups subsequently received a fentanyl (4.0 &#x003bc;g/kg) intravenous push. The incidence and severity of cough were recorded for 1 min after fentanyl administration.</p></sec><sec><title>Results.</title><p> The incidence of FIC was 61%, 40%, and 18% in groups I, II, and III, respectively (<italic>P</italic> &#x0003c; 0.05 for treatment groups II and III versus control group I). There was no significant difference in the severity or onset time of cough, or hemodynamic variables, among the three groups.</p></sec><sec><title>Conclusions.</title><p> Intravenous DEX (0.5 &#x003bc;g/kg or 1 &#x003bc;g/kg) immediately before the administration of intravenous fentanyl (4.0 &#x003bc;g/kg) significantly reduced the incidence of FIC.</p></sec></abstract><kwd-group kwd-group-type="author"><kwd>Cough</kwd><kwd>dexmedetomidine</kwd><kwd>fentanyl</kwd><kwd>opioid-induced muscular rigidity</kwd></kwd-group></article-meta></front><body><sec id="ss1"><title>Introduction</title><p>Fentanyl is commonly administered during general anesthetic induction. Fentanyl-induced cough (FIC) is undesirable as it increases intracranial, intraocular, and intra-abdominal pressures (<xref ref-type="bibr" rid="CIT0001">1</xref>). The incidence of FIC varies from 18% to 65% (<xref ref-type="bibr" rid="CIT0001 CIT0002 CIT0003 CIT0004">1&#x02013;4</xref>). The mechanism of FIC is unclear, and various drugs and techniques are used to reduce its incidence.</p><p>Clonidine was found effective in reducing the incidence of FIC (<xref ref-type="bibr" rid="CIT0005">5</xref>). Dexmedetomidine (DEX), another but more specific &#x003b1;-2 adrenoreceptor agonist, may also be a useful suppressant for FIC.</p><p>We designed a double-blinded, randomized, placebo-controlled study to test our hypothesis that DEX decreases the incidence of FIC.</p></sec><sec sec-type="materials|methods" id="ss2"><title>Materials and methods</title><sec id="ss3"><title>Patient population</title><p>The Ethics Committee of the Second Xiangya Hospital of Central South University approved this study, and all patients gave written informed consent. The study population consisted of 300 patients of both genders, aged 18 to 60 years, classified as American Society of Anesthesiologists (ASA) physical status I or II and scheduled for elective surgery under general anesthesia. Exclusion criteria were: body-weight more than 20% above ideal body-weight (on the basis of body mass index), impaired kidney or liver function, presence of a gastric tube, a history of asthma, chronic cough, smoking, upper respiratory tract infection in the previous 2 weeks, or angiotensin-converting enzyme inhibitor treatments, bronchodilators, or steroids in the previous 2 weeks.</p></sec><sec id="ss4"><title>Anesthesia induction and data collection</title><p>None of the patients received any premedication. Before being taken to the operating room, a 20-gauge cannula was inserted into the dorsum of the patient&#x02019;s hand and connected to a T-connector for drug administration. Upon arrival, standard ASA monitors were attached, including non-invasive arterial pressure, electrocardiography, and pulse oximetry.</p><p>Patients were randomly allocated to three groups (I, II, III; <italic>n</italic> = 100 each) using a computer-generated table of random numbers. All patients were given oxygen via a face mask (2 liters per min). The patients in group I (the control) were given 10 mL isotonic saline intravenously (IV) over 10 min. Patients in groups II and III received DEX 0.5 &#x003bc;g/kg or 1.0 &#x003bc;g/kg, respectively, mixed with isotonic saline to a final volume of 10 mL, over 10 min. A fentanyl bolus (4.0 &#x003bc;g/kg) was then injected into all patients in less than 2 s.</p><p>Beginning immediately, an observer blinded to the treatment group noted during the next 60 s the incidence and severity of cough. Any episode of cough within 60 s of fentanyl administration was classified as FIC, and the severity was graded based on the number of coughs (mild, 1&#x02013;2; moderate, 3&#x02013;4; and severe, &#x02265;5). Mean arterial pressure (MAP) and heart rate (HR) were recorded immediately before injection (T<sub>0</sub>) and every 2 min thereafter for 10 min (T<sub>1&#x02013;5</sub>).</p></sec><sec id="ss5"><title>Statistical analyses</title><p>For the design of this study, an estimation of the required minimum sample size was determined based on a previous report of a cough incidence of 40% after an IV bolus of fentanyl (<xref ref-type="bibr" rid="CIT0001">1</xref>) and an assumption that a pretreatment with DEX would cause a 50% reduction in the incidence of coughing. With a probability of making a type I error (i.e. significance level, &#x003b1;) = 0.05 and the probability of making a type II error (accepting a null hypothesis that is false, &#x003b2;) = 0.20, we were required to enroll at least 91 patients in each group; we recruited 100 patients in each group.</p><p>Data are expressed as number, proportion, percentage, or mean &#x000b1; standard deviation. Statistical analyses were performed using Statistical Product for Social Sciences (SPSS) software 13.0. The frequencies of cough and the proportions of gender and ASA class were compared using the chi-square test or Fisher&#x02019;s exact test with Bonferroni correction. One-way analysis of variance (ANOVA) was used to compare the ages and weights among the three groups. Repeated ANOVA was used to compare the means of continuous data of all three groups. If group differences were found by ANOVA to be significant, they were further analyzed using Tukey&#x02019;s <italic>Post-hoc</italic> test. A probability (<italic>P</italic>) value &#x0003c; 0.05 was considered statistically significant.</p></sec></sec><sec id="ss6"><title>Results</title><sec id="ss7"><title>Demographic characteristics</title><p>All patients completed the study. There were no statistically significant differences among the three groups with regard to age, weight, gender, or ASA class (<xref ref-type="table" rid="T1">Table I</xref>).</p><table-wrap id="T1" orientation="portrait" position="float"><label>Table I.</label><caption><p>Demographics of the control (I) and treatment (II, III) groups (<italic>n</italic> = 100, each)<xref ref-type="fn" rid="T1-N1"><sup>a</sup></xref>.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Demographics</th><th align="center" rowspan="1" colspan="1">Group I</th><th align="center" rowspan="1" colspan="1">Group II</th><th align="center" rowspan="1" colspan="1">Group III</th></tr></thead><tbody valign="top"><tr><td align="left" rowspan="1" colspan="1">Age (y)</td><td align="center" rowspan="1" colspan="1">38.1 &#x000b1; 16.6</td><td align="center" rowspan="1" colspan="1">41.2 &#x000b1; 14.7</td><td align="center" rowspan="1" colspan="1">39.4 &#x000b1; 17.3</td></tr><tr><td align="left" rowspan="1" colspan="1">Gender (M/F), <italic>n</italic></td><td align="center" rowspan="1" colspan="1">62/38</td><td align="center" rowspan="1" colspan="1">59/41</td><td align="center" rowspan="1" colspan="1">65/35</td></tr><tr><td align="left" rowspan="1" colspan="1">Weight (kg)</td><td align="center" rowspan="1" colspan="1">56.4 &#x000b1; 11.6</td><td align="center" rowspan="1" colspan="1">58.3 &#x000b1; 10.9</td><td align="center" rowspan="1" colspan="1">55.9 &#x000b1; 12.1</td></tr><tr><td align="left" rowspan="1" colspan="1">ASA (I/II), <italic>n</italic></td><td align="center" rowspan="1" colspan="1">72/28</td><td align="center" rowspan="1" colspan="1">75/25</td><td align="center" rowspan="1" colspan="1">69/31</td></tr></tbody></table><table-wrap-foot><fn id="T1-N1"><p>
<sup>a</sup>All patients completed the present study. There were no statistically significant differences among the three groups with regard to age, weight, gender, or ASA class.</p></fn></table-wrap-foot></table-wrap></sec><sec id="ss8"><title>Incidence and severity of FIC</title><p>The incidence of FIC was 61% in group I, 40% in group II, and 18% in group III. Groups II and III had a significantly lower incidence than group I (<italic>P</italic> &#x0003c; 0.05). The incidence of FIC in group III was significantly lower than in group II (<italic>P</italic> &#x0003c; 0.05). However, there was no significant difference in the severity or onset time of cough among the three groups (<xref ref-type="table" rid="T2">Table II</xref>).</p><table-wrap id="T2" orientation="portrait" position="float"><label>Table II.</label><caption><p>Incidence, severity, and onset time in seconds of fentanyl-induced cough (FIC) in the control (I) and treatment (II, III) groups (<italic>n</italic> = 100, each).</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">FIC</th><th align="center" rowspan="1" colspan="1">Group I</th><th align="center" rowspan="1" colspan="1">Group II</th><th align="center" rowspan="1" colspan="1">Group III</th></tr></thead><tbody valign="top"><tr><td align="left" rowspan="1" colspan="1">Incidence (%)</td><td align="center" rowspan="1" colspan="1">61</td><td align="center" rowspan="1" colspan="1">40<xref ref-type="fn" rid="T2-N1">a</xref></td><td align="center" rowspan="1" colspan="1">18<xref ref-type="fn" rid="T2-N1">a</xref>,<xref ref-type="fn" rid="T2-N2">b</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Severity</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Mild</td><td align="center" rowspan="1" colspan="1">30</td><td align="center" rowspan="1" colspan="1">19</td><td align="center" rowspan="1" colspan="1">10</td></tr><tr><td align="left" rowspan="1" colspan="1">Moderate</td><td align="center" rowspan="1" colspan="1">23</td><td align="center" rowspan="1" colspan="1">16</td><td align="center" rowspan="1" colspan="1">6</td></tr><tr><td align="left" rowspan="1" colspan="1">Severe</td><td align="center" rowspan="1" colspan="1">8</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">2</td></tr><tr><td align="left" rowspan="1" colspan="1">Onset (s)</td><td align="center" rowspan="1" colspan="1">23.1 &#x000b1; 4.6</td><td align="center" rowspan="1" colspan="1">26.1 &#x000b1; 5.0</td><td align="center" rowspan="1" colspan="1">29.2 &#x000b1; 4.1</td></tr></tbody></table><table-wrap-foot><fn id="T2-N1"><p>
<sup>a</sup>
<italic>P</italic> &#x0003c; 0.05, groups II and III versus group I.</p></fn><fn id="T2-N2"><p>
<sup>b</sup>
<italic>P</italic> &#x0003c; 0.05, group III versus group II.</p></fn></table-wrap-foot></table-wrap><p>There were also no significant differences in the hemodynamics data among the three groups (<xref ref-type="table" rid="T3">Table III</xref>).</p><table-wrap id="T3" orientation="portrait" position="float"><label>Table III.</label><caption><p>Hemodynamics data of the control (I) and treatment (II, III) groups (<italic>n</italic> = 100, each)<xref ref-type="fn" rid="T3-N1"><sup>a</sup></xref>.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">Group</th><th align="center" rowspan="1" colspan="1">T<sub>0</sub></th><th align="center" rowspan="1" colspan="1">T<sub>1</sub></th><th align="center" rowspan="1" colspan="1">T<sub>2</sub></th><th align="center" rowspan="1" colspan="1">T<sub>3</sub></th><th align="center" rowspan="1" colspan="1">T<sub>4</sub></th><th align="center" rowspan="1" colspan="1">T<sub>5</sub></th></tr></thead><tbody valign="top"><tr><td align="left" rowspan="1" colspan="1">MAP (mmHg)</td><td align="left" rowspan="1" colspan="1">I</td><td align="char" char="plusmn" rowspan="1" colspan="1">86.7 &#x000b1; 11.8</td><td align="char" char="plusmn" rowspan="1" colspan="1">85.2 &#x000b1; 12.1</td><td align="char" char="plusmn" rowspan="1" colspan="1">87.2 &#x000b1; 11.3</td><td align="char" char="plusmn" rowspan="1" colspan="1">83.5 &#x000b1; 11.6</td><td align="char" char="plusmn" rowspan="1" colspan="1">86.1 &#x000b1; 10.9</td><td align="char" char="plusmn" rowspan="1" colspan="1">85.3 &#x000b1; 10.7</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">II</td><td align="char" char="plusmn" rowspan="1" colspan="1">83.2 &#x000b1; 11.2</td><td align="char" char="plusmn" rowspan="1" colspan="1">89.2 &#x000b1; 12.3</td><td align="char" char="plusmn" rowspan="1" colspan="1">82.1 &#x000b1; 10.9</td><td align="char" char="plusmn" rowspan="1" colspan="1">82.3 &#x000b1; 10.2</td><td align="char" char="plusmn" rowspan="1" colspan="1">80.5 &#x000b1; 11.6</td><td align="char" char="plusmn" rowspan="1" colspan="1">79.4 &#x000b1; 10.1</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">III</td><td align="char" char="plusmn" rowspan="1" colspan="1">85.1 &#x000b1; 10.1</td><td align="char" char="plusmn" rowspan="1" colspan="1">92.3 &#x000b1; 11.8</td><td align="char" char="plusmn" rowspan="1" colspan="1">83.4 &#x000b1; 10.4</td><td align="char" char="plusmn" rowspan="1" colspan="1">80.1 &#x000b1; 9.80</td><td align="char" char="plusmn" rowspan="1" colspan="1">78.2 &#x000b1; 12.1</td><td align="char" char="plusmn" rowspan="1" colspan="1">77.9 &#x000b1; 10.5</td></tr><tr><td align="left" rowspan="1" colspan="1">HR (bpm)</td><td align="left" rowspan="1" colspan="1">I</td><td align="char" char="plusmn" rowspan="1" colspan="1">77.6 &#x000b1; 14.5</td><td align="char" char="plusmn" rowspan="1" colspan="1">78.2 &#x000b1; 14.1</td><td align="char" char="plusmn" rowspan="1" colspan="1">79.8 &#x000b1; 12.6</td><td align="char" char="plusmn" rowspan="1" colspan="1">76.4 &#x000b1; 13.9</td><td align="char" char="plusmn" rowspan="1" colspan="1">77.3 &#x000b1; 14.7</td><td align="char" char="plusmn" rowspan="1" colspan="1">75.1 &#x000b1; 13.5</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">II</td><td align="char" char="plusmn" rowspan="1" colspan="1">79.2 &#x000b1; 15.0</td><td align="char" char="plusmn" rowspan="1" colspan="1">77.5 &#x000b1; 14.9</td><td align="char" char="plusmn" rowspan="1" colspan="1">75.7 &#x000b1; 13.1</td><td align="char" char="plusmn" rowspan="1" colspan="1">73.4 &#x000b1; 14.3</td><td align="char" char="plusmn" rowspan="1" colspan="1">73.0 &#x000b1; 13.8</td><td align="char" char="plusmn" rowspan="1" colspan="1">2.6 &#x000b1; 13.5</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">III</td><td align="char" char="plusmn" rowspan="1" colspan="1">78.6 &#x000b1; 14.1</td><td align="char" char="plusmn" rowspan="1" colspan="1">75.3 &#x000b1; 13.2</td><td align="char" char="plusmn" rowspan="1" colspan="1">74.1 &#x000b1; 13.5</td><td align="char" char="plusmn" rowspan="1" colspan="1">72.6 &#x000b1; 12.8</td><td align="char" char="plusmn" rowspan="1" colspan="1">71.4 &#x000b1; 13.6</td><td align="char" char="plusmn" rowspan="1" colspan="1">71.2 &#x000b1; 12.3</td></tr></tbody></table><table-wrap-foot><fn id="T3-N1"><p>
<sup>a</sup>There were no significant differences among the groups for either MAP or HR at any time point after DEX injection.</p></fn><fn><p>T<sub>0&#x02013;5</sub> = immediately before DEX injection, and at 2-min intervals, respectively, for 10 min total.</p><p>DEX = dexmedetomidine; HR = heart rate; MAP = mean arterial pressure.</p></fn></table-wrap-foot></table-wrap></sec></sec><sec id="ss9"><title>Discussion</title><p>This study demonstrated that pretreatment with DEX, 0.5 and 1 &#x003bc;g/kg, reduced the incidence of FIC from 61% (in the untreated control) to 40% and 18%, respectively. However, the severity and onset time of cough was unaffected, and no significant hemodynamic changes were observed following DEX administration.</p><p>DEX, an &#x003b1;<sub>2</sub>-adrenoreceptor agonist, is widely used in the anesthetic setting and in intensive care (<xref ref-type="bibr" rid="CIT0006 CIT0007 CIT0008 CIT0009 CIT0010 CIT0011 CIT0012 CIT0013">6&#x02013;13</xref>). This is the first report on the effect of DEX on FIC, although the less specific &#x003b1;<sub>2</sub>-adrenoreceptor agonist clonidine has been demonstrated to reduce the incidence of FIC (<xref ref-type="bibr" rid="CIT0005">5</xref>).</p><p>Many mechanisms have been proposed to explain FIC. These include the stimulation of vagal C-fiber (J or juxtacapillary) receptors, citric acid stimulating C-fibers in the airway, the release of histamine from lung mast cells, sudden adduction of the vocal cords or supraglottic obstruction by soft tissue, deformation of the tracheobronchial wall stimulating irritant receptors that lead to reflex bronchoconstriction and cough, and the release of neuropeptides from prejunctional &#x003bc;-opioid receptors (<xref ref-type="bibr" rid="CIT0002 CIT0003 CIT0014 CIT0015 CIT0016 CIT0017 CIT0018">2,3,14&#x02013;18</xref>), Fentanyl-induced muscle rigidity is another important causal factor. The &#x003b1;<sub>2</sub>-adrenoreceptor agonists&#x02019; ability to reverse opioid-induced muscular rigidity has been demonstrated in rats (<xref ref-type="bibr" rid="CIT0019">19</xref>). It is possible that &#x003b1;<sub>2</sub>-adrenoreceptor agonists reduce the incidence of FIC via reversal of fentanyl-induced muscular rigidity and not through sedation (<xref ref-type="bibr" rid="CIT0020">20</xref>). The investigation by Horng et al. (<xref ref-type="bibr" rid="CIT0005">5</xref>) demonstrated that clonidine could suppress FIC in humans. Thus, we suggest in this study that the effect of DEX on FIC occurs via reversal of fentanyl-induced muscular rigidity.</p><p>Many physical methods and drugs have been reported to prevent FIC, including propofol, lidocaine, and ephedrine (<xref ref-type="bibr" rid="CIT0001 CIT0003 CIT0005 CIT0014 CIT0017 CIT0021 CIT0022">1,3,5,14,17,21,22</xref>). All reported methods have variable effectiveness and potential side effects. The efficacy of physical methods for reducing FIC remains controversial. The investigation by Yu et al. (<xref ref-type="bibr" rid="CIT0004">4</xref>) demonstrated that dilution of fentanyl combined with a prolonged injection time could eliminate FIC. However, according to Sch&#x000e4;permeier and Hopf&#x02019;s study (<xref ref-type="bibr" rid="CIT0023">23</xref>), FIC does not depend on injection speed. A huffing maneuver was reported as a useful way to prevent FIC (<xref ref-type="bibr" rid="CIT0024">24</xref>), but some patients who receive midazolam or propofol during induction of general anesthesia cannot use this maneuver.</p><p>Although the above-mentioned medications could reduce the incidence of coughing, some unexpected side-effects may occur during drug administration, such as malignant arrhythmia, hypotension, and hypertension. Pretreatment with lidocaine can augment the cardiovascular depression of induction agents (<xref ref-type="bibr" rid="CIT0025">25</xref>). Intravenous ephedrine before fentanyl injection can be contraindicated in patients with coronary artery disease or moderate to severe hypertension (<xref ref-type="bibr" rid="CIT0024">24</xref>). Using high doses of propofol can be associated with a high incidence of hypotension (<xref ref-type="bibr" rid="CIT0022">22</xref>). Pretreatment with clonidine is also associated with respiratory depression, drowsiness, and severe hypotension (<xref ref-type="bibr" rid="CIT0005">5</xref>).</p><p>Pretreatment with DEX has been reported to cause significant hemodynamic changes (<xref ref-type="bibr" rid="CIT0026">26</xref>). However, our study demonstrates that DEX in doses of 0.5 &#x003bc;g/kg or 1 &#x003bc;g/kg can be safely used preoperatively, with stable hemodynamics. A report of Koroglu et al. showed that a high dose of DEX (a bolus of 2&#x02013;3 &#x003bc;g/kg over 10 min or infusion of 1.5&#x02013;3.0 &#x003bc;g/kg&#x000b7;h) in children undergoing MRI produced bradycardia in 16% of these patients. However, the MAP and oxygen saturation remained within normal range, and no adverse sequelae were observed and no specific treatment was required (<xref ref-type="bibr" rid="CIT0013">13</xref>).</p><p>A limitation of this study was that a dose-response experiment was not performed to determine the optimal dose of DEX that produces the maximum depression of FIC without causing side effects. However, our choice of doses was based on the DEX dose used in premedication (<xref ref-type="bibr" rid="CIT0027">27</xref>). DEX is used as a premedicant in doses of 0.5 to 1 &#x003bc;g/kg because of its sedative and anesthetic-sparing effects, as well as attenuating airway/circulatory reflexes during anesthesia (<xref ref-type="bibr" rid="CIT0011">11</xref>). We chose the doses 0.5 &#x003bc;g/kg and 1 &#x003bc;g/kg and achieved satisfactory effects, whilst maintaining hemodynamic stability. Further studies are warranted to determine the optimum dose of DEX that will suppress FIC without causing side effects.</p><p>In conclusion, intravenous DEX (0.5 &#x003bc;g/kg or 1 &#x003bc;g/kg) given immediately before the administration of IV fentanyl (4.0 &#x003bc;g/kg) is a convenient way to reduce the incidence of FIC.</p></sec></body><back><ack><p>
<bold><italic>Declaration of interest:</italic></bold> The authors report no conflicts of interest. The authors alone are responsible for the content and writing of this paper.</p></ack><ref-list><title>References</title><ref id="CIT0001"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>CS</given-names></name><name><surname>Sun</surname><given-names>WZ</given-names></name><name><surname>Chan</surname><given-names>WH</given-names></name><name><surname>Lin</surname><given-names>CJ</given-names></name><name><surname>Yeh</surname><given-names>HM</given-names></name><name><surname>Mok</surname><given-names>MS</given-names></name></person-group><article-title>Intravenous lidocaine and ephedrine, but not propofol, suppress fentanyl-induced cough</article-title><source>Can J Anaesth</source><year>2004</year><volume>51</volume><fpage>654</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">15310631</pub-id></element-citation></ref><ref id="CIT0002"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agarwal</surname><given-names>A</given-names></name><name><surname>Azim</surname><given-names>A</given-names></name><name><surname>Ambesh</surname><given-names>S</given-names></name><name><surname>Bose</surname><given-names>N</given-names></name><name><surname>Dhiraj</surname><given-names>S</given-names></name><name><surname>Sahu</surname><given-names>D</given-names></name><etal/></person-group><article-title>Salbutamol, beclomethasone or sodium chromoglycate suppress coughing induced by iv fentanyl</article-title><source>Can J Anaesth</source><year>2003</year><volume>50</volume><fpage>297</fpage><lpage>300</lpage><pub-id pub-id-type="pmid">12620955</pub-id></element-citation></ref><ref id="CIT0003"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>JA</given-names></name><name><surname>Yeh</surname><given-names>CC</given-names></name><name><surname>Lee</surname><given-names>MS</given-names></name><name><surname>Wu</surname><given-names>CT</given-names></name><name><surname>Lin</surname><given-names>SL</given-names></name><name><surname>Wong</surname><given-names>CS</given-names></name></person-group><article-title>Prolonged injection time and light smoking decrease the incidence of fentanyl-induced cough</article-title><source>Anesth Analg</source><year>2005</year><volume>101</volume><fpage>670</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">16115973</pub-id></element-citation></ref><ref id="CIT0004"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>H</given-names></name><name><surname>Yang</surname><given-names>XY</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>Q</given-names></name><name><surname>Zhu</surname><given-names>T</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><etal/></person-group><article-title>The effect of dilution and prolonged injection time on fentanyl induced coughing</article-title><source>Anesthesia</source><year>2007</year><volume>62</volume><fpage>919</fpage><lpage>22</lpage></element-citation></ref><ref id="CIT0005"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Horng</surname><given-names>HC</given-names></name><name><surname>Wong</surname><given-names>CS</given-names></name><name><surname>Hsiao</surname><given-names>KN</given-names></name><name><surname>Huh</surname><given-names>BK</given-names></name><name><surname>Kuo</surname><given-names>CP</given-names></name><name><surname>Cherng</surname><given-names>CH</given-names></name><etal/></person-group><article-title>Pre-medication with intravenous clonidine suppresses fentanyl-induced cough</article-title><source>Acta Anaesthesiol Scand</source><year>2007</year><volume>51</volume><fpage>862</fpage><lpage>65</lpage><pub-id pub-id-type="pmid">17578464</pub-id></element-citation></ref><ref id="CIT0006"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vilo</surname><given-names>S</given-names></name><name><surname>Rautiainen</surname><given-names>P</given-names></name><name><surname>Kaisti</surname><given-names>K</given-names></name><name><surname>Aantaa</surname><given-names>R</given-names></name><name><surname>Scheinin</surname><given-names>M</given-names></name><name><surname>Manner</surname><given-names>T</given-names></name><etal/></person-group><article-title>Pharmacokinetics of intravenous dexmedetomidine in children under 11 yr of age</article-title><source>Br J Anaesth</source><year>2008</year><volume>100</volume><fpage>697</fpage><lpage>700</lpage><pub-id pub-id-type="pmid">18378546</pub-id></element-citation></ref><ref id="CIT0007"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kadoi</surname><given-names>Y</given-names></name><name><surname>Saito</surname><given-names>S</given-names></name><name><surname>Kawauchi</surname><given-names>C</given-names></name><name><surname>Hinohara</surname><given-names>H</given-names></name><name><surname>Kunimoto</surname><given-names>F</given-names></name></person-group><article-title>Comparative effects of propofol vs dexmedetomidine on cerebrovascular carbon dioxide reactivity in patients with septic shock</article-title><source>Br J Anaesth</source><year>2008</year><volume>100</volume><fpage>224</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">18178608</pub-id></element-citation></ref><ref id="CIT0008"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tanskanen</surname><given-names>PE</given-names></name><name><surname>Kytt&#x000e4;</surname><given-names>JV</given-names></name><name><surname>Randell</surname><given-names>TT</given-names></name><name><surname>Aantaa</surname><given-names>RE</given-names></name></person-group><article-title>Dexmedetomidine as an anaesthetic adjuvant in patients undergoing intracranial tumour surgery: a double-blind, randomized and placebo controlled study</article-title><source>Br J Anaesth</source><year>2006</year><volume>97</volume><fpage>658</fpage><lpage>65</lpage><pub-id pub-id-type="pmid">16914460</pub-id></element-citation></ref><ref id="CIT0009"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shehabi</surname><given-names>Y</given-names></name><name><surname>Ruettimann</surname><given-names>U</given-names></name><name><surname>Adamson</surname><given-names>H</given-names></name><name><surname>Innes</surname><given-names>R</given-names></name><name><surname>Ickeringill</surname><given-names>M</given-names></name></person-group><article-title>Dexmedetomidine infusion for more than 24 hours in critically ill patients: sedative and cardiovascular effects</article-title><source>Intensive Care Med</source><year>2004</year><volume>30</volume><fpage>2188</fpage><lpage>96</lpage><pub-id pub-id-type="pmid">15338124</pub-id></element-citation></ref><ref id="CIT0010"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Venn</surname><given-names>M</given-names></name><name><surname>Newman</surname><given-names>J</given-names></name><name><surname>Grounds</surname><given-names>M</given-names></name></person-group><article-title>A phase II study to evaluate the efficacy of dexmedetomidine for sedation in the medical intensive care unit</article-title><source>Intensive Care Med</source><year>2003</year><volume>29</volume><fpage>201</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">12594584</pub-id></element-citation></ref><ref id="CIT0011"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guler</surname><given-names>G</given-names></name><name><surname>Akin</surname><given-names>A</given-names></name><name><surname>Tosun</surname><given-names>Z</given-names></name><name><surname>Eskitascoglu</surname><given-names>E</given-names></name><name><surname>Mizrak</surname><given-names>A</given-names></name><name><surname>Boyaci</surname><given-names>A</given-names></name></person-group><article-title>Single-dose dexmedetomidine attenuates airway and circulatory reflexes during extubation</article-title><source>Acta Anaesthesiol Scand</source><year>2005</year><volume>49</volume><fpage>1088</fpage><lpage>91</lpage><pub-id pub-id-type="pmid">16095449</pub-id></element-citation></ref><ref id="CIT0012"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karakaya Kabuk&#x000e7;u</surname><given-names>H</given-names></name><name><surname>Sahin</surname><given-names>N</given-names></name><name><surname>Temel</surname><given-names>Y</given-names></name><name><surname>Aydogdu Titiz</surname><given-names>TA</given-names></name></person-group><article-title>Hemodynamics in coronary artery bypass surgery: Effects of intraoperative dexmedetomidine administration</article-title><source>Anaesthesist</source><year>2011</year><volume>60</volume><fpage>427</fpage><lpage>31</lpage><pub-id pub-id-type="pmid">21271232</pub-id></element-citation></ref><ref id="CIT0013"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koroglu</surname><given-names>A</given-names></name><name><surname>Demirbilek</surname><given-names>S</given-names></name><name><surname>Teksan</surname><given-names>H</given-names></name><name><surname>Sagir</surname><given-names>O</given-names></name><name><surname>But</surname><given-names>AK</given-names></name><name><surname>Ersoy</surname><given-names>MO</given-names></name></person-group><article-title>Sedative, hemodynamic and respiratory effects of dexmedetomidine in children undergoing magnetic resonance imaging examination: preliminary results</article-title><source>Br J Anaesth</source><year>2005</year><volume>94</volume><fpage>821</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">15764627</pub-id></element-citation></ref><ref id="CIT0014"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pandey</surname><given-names>CK</given-names></name><name><surname>Raza</surname><given-names>M</given-names></name><name><surname>Ranjan</surname><given-names>R</given-names></name><name><surname>Singhal</surname><given-names>V</given-names></name><name><surname>Kumar</surname><given-names>M</given-names></name><name><surname>Lakra</surname><given-names>A</given-names></name><etal/></person-group><article-title>Intravenous lidocaine 0.5 mg/kg effectively suppresses fentanyl-induced cough</article-title><source>Can J Anaesth</source><year>2005</year><volume>52</volume><fpage>172</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">15684258</pub-id></element-citation></ref><ref id="CIT0015"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tanaka</surname><given-names>M</given-names></name><name><surname>Maruyama</surname><given-names>K</given-names></name></person-group><article-title>Mechanisms of capsaicin and citric-acid-induced cough reflexes in Guinea pigs</article-title><source>J Pharmacol Sci</source><year>2005</year><volume>99</volume><fpage>77</fpage><lpage>82</lpage><pub-id pub-id-type="pmid">16127241</pub-id></element-citation></ref><ref id="CIT0016"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bennett</surname><given-names>JA</given-names></name><name><surname>Abrams</surname><given-names>JT</given-names></name><name><surname>VanRiper</surname><given-names>DF</given-names></name><name><surname>Horrow</surname><given-names>JC</given-names></name></person-group><article-title>Difficult or impossible ventilation after sufentanil-induced anesthesia is caused primarily by vocal cord closure</article-title><source>Anesthesiology</source><year>1997</year><volume>87</volume><fpage>1070</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">9366458</pub-id></element-citation></ref><ref id="CIT0017"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ai</surname><given-names>Q</given-names></name><name><surname>Hu</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Wu</surname><given-names>S</given-names></name><name><surname>Qin</surname><given-names>Z</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><etal/></person-group><article-title>Pentazocine pretreatment suppresses fentanyl-induced cough</article-title><source>Pharmacol Rep</source><year>2010</year><volume>62</volume><fpage>747</fpage><lpage>50</lpage><pub-id pub-id-type="pmid">20885016</pub-id></element-citation></ref><ref id="CIT0018"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agarwal</surname><given-names>A</given-names></name><name><surname>Gautam</surname><given-names>S</given-names></name><name><surname>Nath</surname><given-names>SS</given-names></name><name><surname>Gupta</surname><given-names>D</given-names></name><name><surname>Singh</surname><given-names>U</given-names></name></person-group><article-title>Comparison of the incidence and severity of cough induced by sufentanil and fentanyl: a prospective, randomised, double-blind study</article-title><source>Anesthesia</source><year>2007</year><volume>62</volume><fpage>1230</fpage><lpage>2</lpage></element-citation></ref><ref id="CIT0019"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weinger</surname><given-names>MB</given-names></name><name><surname>Chen</surname><given-names>DY</given-names></name><name><surname>Lin</surname><given-names>T</given-names></name><name><surname>Lau</surname><given-names>C</given-names></name><name><surname>Koob</surname><given-names>GF</given-names></name><name><surname>Smith</surname><given-names>NT</given-names></name></person-group><article-title>A role for CNS alpha-2 adrenergic receptors in opioid induced muscle rigidity in the rat</article-title><source>Brain Res</source><year>1995</year><volume>669</volume><fpage>10</fpage><lpage>18</lpage><pub-id pub-id-type="pmid">7712151</pub-id></element-citation></ref><ref id="CIT0020"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hung</surname><given-names>KC</given-names></name></person-group><article-title>The possible mechanism of clonidine to suppress fentanyl-induced coughing</article-title><source>Acta Anaesthesiol Scand</source><year>2009</year><volume>53</volume><fpage>1227</fpage><lpage>8</lpage></element-citation></ref><ref id="CIT0021"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oshima</surname><given-names>T</given-names></name><name><surname>Kasuya</surname><given-names>Y</given-names></name><name><surname>Okumura</surname><given-names>Y</given-names></name><name><surname>Murakami</surname><given-names>T</given-names></name><name><surname>Dohi</surname><given-names>S</given-names></name></person-group><article-title>Identification of independent risk factors for fentanyl-induced cough</article-title><source>Can J Anaesth</source><year>2006</year><volume>53</volume><fpage>753</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">16873340</pub-id></element-citation></ref><ref id="CIT0022"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>Q</given-names></name><name><surname>Qian</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>Q</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name></person-group><article-title>Effects of different priming doses of propofol on fentanyl-induced cough during anesthesia induction: a preliminary randomized controlled study</article-title><source>Ups J Med Sci</source><year>2010</year><volume>115</volume><fpage>121</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">19824805</pub-id></element-citation></ref><ref id="CIT0023"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sch&#x000e4;permeier</surname><given-names>U</given-names></name><name><surname>Hopf</surname><given-names>HB</given-names></name></person-group><article-title>Fentanyl-induced cough does not depend on injection speed: a randomized study</article-title><source>Acta Anaesthesiol Scand</source><year>2008</year><volume>52</volume><fpage>1071</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">18840106</pub-id></element-citation></ref><ref id="CIT0024"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ambesh</surname><given-names>SP</given-names></name><name><surname>Singh</surname><given-names>N</given-names></name><name><surname>Gupta</surname><given-names>D</given-names></name><name><surname>Singh</surname><given-names>PK</given-names></name><name><surname>Singh</surname><given-names>U</given-names></name></person-group><article-title>A huffing manoeuvre, immediately before induction of anesthesia, prevents fentanyl-induced coughing: a prospective, randomized, and controlled study</article-title><source>Br J Anaesth</source><year>2010</year><volume>104</volume><fpage>40</fpage><lpage>3</lpage><pub-id pub-id-type="pmid">19933512</pub-id></element-citation></ref><ref id="CIT0025"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schlimp</surname><given-names>CJ</given-names></name><name><surname>Wiedermann</surname><given-names>FJ</given-names></name></person-group><article-title>Does fentanyl-induced cough justify pre-treatment with i.v. lidocaine 2 mg/kg</article-title><source>Can J Anaesth</source><year>2005</year><volume>52</volume><fpage>207</fpage><pub-id pub-id-type="pmid">15684266</pub-id></element-citation></ref><ref id="CIT0026"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ebert</surname><given-names>TJ</given-names></name><name><surname>Hall</surname><given-names>JE</given-names></name><name><surname>Barney</surname><given-names>JA</given-names></name><name><surname>Uhrich</surname><given-names>TD</given-names></name><name><surname>Colinco</surname><given-names>MD</given-names></name></person-group><article-title>The effects of increasing plasma concentrations of dexmedetomidine in humans</article-title><source>Anesthesiology</source><year>2000</year><volume>93</volume><fpage>382</fpage><lpage>94</lpage><pub-id pub-id-type="pmid">10910487</pub-id></element-citation></ref><ref id="CIT0027"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kunisawa</surname><given-names>T</given-names></name><name><surname>Nagata</surname><given-names>O</given-names></name><name><surname>Nagashima</surname><given-names>M</given-names></name><name><surname>Mitamura</surname><given-names>S</given-names></name><name><surname>Ueno</surname><given-names>M</given-names></name><name><surname>Suzuki</surname><given-names>A</given-names></name><etal/></person-group><article-title>Dexmedetomidine suppresses the decrease in blood pressure during anesthetic induction and blunts the cardiovascular response to tracheal intubation</article-title><source>J Clin Anesth</source><year>2009</year><volume>21</volume><fpage>194</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">19464613</pub-id></element-citation></ref></ref-list></back></article>